{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T09:41:09Z","timestamp":1758706869837},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2008,7,16]],"date-time":"2008-07-16T00:00:00Z","timestamp":1216166400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0002709","type":"journal-article","created":{"date-parts":[[2008,7,15]],"date-time":"2008-07-15T22:14:53Z","timestamp":1216160093000},"page":"e2709","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Analysis of Venezuelan Equine Encephalitis Replicon Particles Packaged in Different Coats"],"prefix":"10.1371","volume":"3","author":[{"given":"Kurt I.","family":"Kamrud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim D.","family":"Alterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chasity","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura O.","family":"Copp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Whitney C.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bolyn","family":"Hubby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepa","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan O.","family":"Rayner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd","family":"Talarico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan F.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2008,7,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/MMBR.58.3.491-562.1994","article-title":"The alphaviruses: gene expression, replication, and evolution.","volume":"58","author":"JH Strauss","year":"1994","journal-title":"Microbiol Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0042-6822(88)90484-9","article-title":"Selection for accelerated penetration in cell culture coselects for attenuated mutants of Venezuelan equine encephalitis virus.","volume":"162","author":"RE Johnston","year":"1988","journal-title":"Virology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0042-6822(91)90114-Q","article-title":"Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone.","volume":"183","author":"NL Davis","year":"1991","journal-title":"Virology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1006\/viro.1995.1458","article-title":"Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1.","volume":"212","author":"NL Davis","year":"1995","journal-title":"Virology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1006\/viro.1995.1022","article-title":"Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins.","volume":"206","author":"FB Grieder","year":"1995","journal-title":"Virology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.4269\/ajtmh.1999.60.1041","article-title":"Limited potential for mosquito transmission of genetically engineered, live-attenuated Venezuelan equine encephalitis virus vaccine candidates.","volume":"60","author":"MJ Turell","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/viro.2000.0546","article-title":"Mutations in the E2 glycoprotein of Venezuelan equine encephalitis virus confer heparan sulfate interaction, low morbidity, and rapid clearance from blood of mice.","volume":"276","author":"KA Bernard","year":"2000","journal-title":"Virology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1006\/viro.1997.8878","article-title":"Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.","volume":"239","author":"P Pushko","year":"1997","journal-title":"Virology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.virol.2006.10.049","article-title":"Alphavirus replicon approach to promoterless analysis of IRES elements.","volume":"360","author":"KI Kamrud","year":"2007","journal-title":"Virology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1128\/JVI.74.2.914-922.2000","article-title":"Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis.","volume":"74","author":"GH MacDonald","year":"2000","journal-title":"J Virol"},{"key":"ref11","first-page":"203","article-title":"Alphaviral-Based Strategies for the Immunotherapy of Cancer.","author":"ED Nelson","year":"2004"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1089\/vim.2006.0090","article-title":"Restricted and selective tropism of a Venezuelan equine encephalitis virus-derived replicon vector for human dendritic cells.","volume":"20","author":"KP Nishimoto","year":"2007","journal-title":"Viral Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0264-410X(00)00113-4","article-title":"Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus.","volume":"19","author":"P Pushko","year":"2000","journal-title":"Vaccine"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"11677","DOI":"10.1128\/JVI.75.23.11677-11685.2001","article-title":"Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses.","volume":"75","author":"P Pushko","year":"2001","journal-title":"J Virol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1006\/viro.2000.0635","article-title":"Influenza virus (A\/HK\/156\/97) hemagglutinin expressed by an alphavirus replicon system protects chickens against lethal infection with Hong Kong-origin H5N1 viruses.","volume":"278","author":"S Schultz-Cherry","year":"2000","journal-title":"Virology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1128\/IAI.69.9.5709-5715.2001","article-title":"Candidate vaccine against botulinum neurotoxin serotype A derived from a Venezuelan equine encephalitis virus vector system.","volume":"69","author":"JS Lee","year":"2001","journal-title":"Infect Immun"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1086\/339677","article-title":"Immune protection against staphylococcal enterotoxin-induced toxic shock by vaccination with a Venezuelan equine encephalitis virus replicon.","volume":"185","author":"JS Lee","year":"2002","journal-title":"J Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1128\/IAI.71.3.1491-1496.2003","article-title":"Venezuelan equine encephalitis virus-vectored vaccines protect mice against anthrax spore challenge.","volume":"71","author":"JS Lee","year":"2003","journal-title":"Infect Immun"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"6886","DOI":"10.1016\/j.vaccine.2006.06.004","article-title":"Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice.","volume":"24","author":"JS Lee","year":"2006","journal-title":"Vaccine"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1006\/viro.2001.1012","article-title":"Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins.","volume":"286","author":"JA Wilson","year":"2001","journal-title":"Virology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1128\/JVI.75.6.2660-2664.2001","article-title":"Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein.","volume":"75","author":"JA Wilson","year":"2001","journal-title":"J Virol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1006\/viro.1998.9367","article-title":"Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates.","volume":"251","author":"M Hevey","year":"1998","journal-title":"Virology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0264-410X(01)00485-6","article-title":"Alphavirus replicon particles expressing the two major envelope proteins of equine arteritis virus induce high level protection against challenge with virulent virus in vaccinated horses.","volume":"20","author":"UB Balasuriya","year":"2002","journal-title":"Vaccine"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/088922203762688649","article-title":"Characterization and selection of HIV-1 subtype C isolates for use in vaccine development.","volume":"19","author":"C Williamson","year":"2003","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/15216540212657","article-title":"Alphavirus replicon particles as candidate HIV vaccines.","volume":"53","author":"NL Davis","year":"2002","journal-title":"IUBMB Life"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/B:BREA.0000004373.09678.bb","article-title":"Venezuelan equine encephalitis replicon immunization overcomes intrinsic tolerance and elicits effective anti-tumor immunity to the \u2018self\u2019 tumor-associated antigen, neu in a rat mammary tumor model.","volume":"82","author":"EL Nelson","year":"2003","journal-title":"Breast Cancer Res Treat"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1128\/IAI.17.2.356-360.1977","article-title":"Evaluation of vascular clearance as a marker for virulence of alphaviruses: Disassociation of rapid clearance with low virulence of Venezuelan encephalitis virus strains in guinea pigs.","volume":"17","author":"P Jahrling","year":"1977","journal-title":"Infection and Immunity"},{"key":"ref28","first-page":"99","article-title":"A molecular genetic approach to the study of Venezuelan equine encephalitis virus pathogenesis.","volume":"9","author":"NL Davis","year":"1994","journal-title":"Archives of Virology Suppl."},{"key":"ref29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4269\/ajtmh.2001.64.49","article-title":"Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice.","volume":"64","author":"GV Ludwig","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1006\/viro.2000.0241","article-title":"A single-site mutant and revertants arising in vivo define early steps in the pathogenesis of Venezuelan equine encephalitis virus.","volume":"270","author":"JF Aronson","year":"2000","journal-title":"Virology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1128\/JVI.67.3.1269-1277.1993","article-title":"Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5\u2032-noncoding region and the E2 envelope glycoprotein.","volume":"67","author":"RM Kinney","year":"1993","journal-title":"J Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"10623","DOI":"10.1128\/JVI.74.22.10623-10630.2000","article-title":"Expression of the two major envelope proteins of equine arteritis virus as a heterodimer is necessary for induction of neutralizing antibodies in mice immunized with recombinant Venezuelan equine encephalitis virus replicon particles.","volume":"74","author":"UB Balasuriya","year":"2000","journal-title":"J Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1128\/JVI.74.1.371-378.2000","article-title":"Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles.","volume":"74","author":"NL Davis","year":"2000","journal-title":"J Virol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1126\/science.287.5458.1664","article-title":"Epitopes involved in antibody-mediated protection from Ebola virus.","volume":"287","author":"JA Wilson","year":"2000","journal-title":"Science"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1016\/j.vaccine.2005.05.034","article-title":"Vaccination of macaques with SIV immunogens delivered by Venezuelan equine encephalitis virus replicon particle vectors followed by a mucosal challenge with SIVsmE660.","volume":"23","author":"RE Johnston","year":"2005","journal-title":"Vaccine"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1128\/JVI.75.8.3706-3718.2001","article-title":"Role of alpha\/beta interferon in Venezuelan equine encephalitis virus pathogenesis: effect of an attenuating mutation in the 5\u2032 untranslated region.","volume":"75","author":"LJ White","year":"2001","journal-title":"J Virol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1128\/JVI.74.7.3366-3378.2000","article-title":"Alpha\/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism.","volume":"74","author":"KD Ryman","year":"2000","journal-title":"J Virol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1128\/JVI.79.3.1487-1499.2005","article-title":"Sindbis virus translation is inhibited by a PKR\/RNase L-independent effector induced by alpha\/beta interferon priming of dendritic cells.","volume":"79","author":"KD Ryman","year":"2005","journal-title":"J Virol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"7729","DOI":"10.1128\/JVI.00425-06","article-title":"Ribosomal protein S6 associates with alphavirus nonstructural protein 2 and mediates expression from alphavirus messages.","volume":"80","author":"SA Montgomery","year":"2006","journal-title":"J Virol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1101\/gad.357006","article-title":"Translational resistance of late alphavirus mRNA to eIF2alpha phosphorylation: a strategy to overcome the antiviral effect of protein kinase PKR.","volume":"20","author":"I Ventoso","year":"2006","journal-title":"Genes Dev"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"10394","DOI":"10.1128\/JVI.77.19.10394-10403.2003","article-title":"An alphavirus replicon particle chimera derived from Venezuelan equine encephalitis and Sindbis viruses is a potent gene-based vaccine delivery vector.","volume":"77","author":"S Perri","year":"2003","journal-title":"J Virol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1073\/pnas.0600287103","article-title":"Mucosal and systemic adjuvant activity of alphavirus replicon particles.","volume":"103","author":"JM Thompson","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0042-6822(89)90526-6","article-title":"In vitro synthesis of infectious Venezuelan equine encephalitis virus RNA from a cDNA clone: analysis of a viable deletion mutant.","volume":"171","author":"NL Davis","year":"1989","journal-title":"Virology"},{"key":"ref44","first-page":"209","article-title":"Attenuation of Venezuelan equine encephalomyelitis virus by in vitro cultivation in guinea pig heart cells.","volume":"73","author":"TO Berge","year":"1961","journal-title":"American Journal of Hygiene"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1128\/CVI.00037-07","article-title":"Cellular and humoral immune responses to alphavirus replicon vaccines expressing cytomegalovirus pp65, IE1, and gB proteins.","volume":"14","author":"EA Reap","year":"2007","journal-title":"Clin Vaccine Immunol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0002709","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T07:05:10Z","timestamp":1589007910000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0002709"}},"subtitle":[],"editor":[{"given":"Brett","family":"Lindenbach","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2008,7,16]]},"references-count":45,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2008,7,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0002709","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,16]]}}}